Start with AquaVita’s one-month listing
The AquaVita review compares the $215 and $320 one-month catalog prices with the larger three-month purchases. Ask for the selected total and the refund terms before paying.
Head-to-head · WeighScore
By GLP-1 ScorecardUpdated
SkinnyRx advertises a lower first-month injection price. AquaVita makes it easier to compare the listed cost of one supply with a three-month purchase.
The AquaVita review compares the $215 and $320 one-month catalog prices with the larger three-month purchases. Ask for the selected total and the refund terms before paying.
The SkinnyRx review separates its $99 first-month injection offer from the still-unconfirmed recurring price and explains when to cancel before renewal processing.
A first-month offer does not establish the total for three months. Confirm the prescription, usable supply and cancellation deadline.
Score comparison
SkinnyRx has the higher recorded score — 60.5/100 to 56.3/100.
SkinnyRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes four introductory compounded-treatment offers, but continuing costs, usable supply and the interaction between cancellation and refund rules need confirmation.
Before comparing the headline prices, the AquaVita NextGen review and the SkinnyRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AquaVita NextGen vs TeleCareSpot and CoreAge Rx vs SkinnyRx compare each of them with another graded program, and the list of alternatives to AquaVita NextGen ranks the programs closest to AquaVita NextGen on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
Swipe or scroll to compare both providers.
| Metric | AquaVita NextGen | SkinnyRx |
|---|---|---|
| WeighScore | 56.3/100 | 60.5/100 |
| Grade | C | C |
| Site position | #447 | #274 |
| Semaglutide | $215 for one month or $600 for three months; confirm total | Injection advertised $99 first month; compounded tablets $149 first month. Confirm the recurring price, selected term and usable prescription supply. |
| Tirzepatide | $320 for one month or $900 for three months; confirm total | Injection advertised $99 first month; compounded dissolving tablets $199 first month. Confirm the recurring price, selected term and usable prescription supply. |
| Coverage | 5 states listed | Current terms exclude certain compounded offerings in Alabama, Louisiana and Mississippi; confirm eligibility for the exact route and pharmacy. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Yes |
Strengths
What to consider
Site position #274 · C
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Strengths
What to consider
Featured provider
SkinnyRx scores 60.5/100 (C). Publishes four introductory compounded-treatment offers, but continuing costs, usable supply and the interaction between cancellation and refund rules need confirmation.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.